Recruiting PHASE1 INTERVENTIONAL 4-arm NCT06446531

Prevention of Progression of Prediabetes, Obesity and CV Risk (Pre-DM)

Pioneering and Affordable Strategies to Prevent Progression of Prediabetes, Obesity and CV Risk in Hispanics

Sponsor: Baptist Health Foundation of San Antonio

Conditions Cardiovascular Diseases Pre-Diabetes Weight, Body

Interventions Actos Jardiance 25Mg Tablet Metformin Placebo Rybelsus Tablet

Updated 4 times since 2024 Last updated: Nov 10, 2025 Started: Sep 11, 2024 Primary completion: Jul 31, 2027 Completion: Jul 31, 2027

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06446531, this PHASE1 trial focuses on Cardiovascular Diseases and Pre-Diabetes and remains actively recruiting participants. Sponsored by Baptist Health Foundation of San Antonio, it has been updated 4 times since 2024, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

4 versions recorded

Dec 2025 — Present [monthly]

Recruiting PHASE1
Nov 2024 — Dec 2025 [monthly]

Recruiting PHASE1
Sep 2024 — Nov 2024 [monthly]

Recruiting PHASE1
Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE1

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Baptist Health Foundation of San Antonio
The University of Texas Health Science Center at San Antonio

Data source: The University of Texas Health Science Center at San Antonio

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• San Antonio, United States